B. Metzler seel. Sohn & Co. AG Grows Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

B. Metzler seel. Sohn & Co. AG increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 20,861 shares of the medical equipment provider’s stock after buying an additional 552 shares during the period. B. Metzler seel. Sohn & Co. AG’s holdings in Intuitive Surgical were worth $10,889,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Rodgers Brothers Inc. bought a new position in shares of Intuitive Surgical during the fourth quarter worth about $343,000. Summit Financial LLC lifted its holdings in Intuitive Surgical by 28.4% during the 4th quarter. Summit Financial LLC now owns 8,427 shares of the medical equipment provider’s stock worth $4,398,000 after buying an additional 1,865 shares during the last quarter. AIA Group Ltd lifted its holdings in Intuitive Surgical by 4.1% during the 4th quarter. AIA Group Ltd now owns 18,533 shares of the medical equipment provider’s stock worth $9,673,000 after buying an additional 722 shares during the last quarter. Hazlett Burt & Watson Inc. grew its position in shares of Intuitive Surgical by 87.0% in the 4th quarter. Hazlett Burt & Watson Inc. now owns 677 shares of the medical equipment provider’s stock worth $352,000 after acquiring an additional 315 shares in the last quarter. Finally, Everstar Asset Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $213,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Down 3.2 %

Shares of Intuitive Surgical stock opened at $491.84 on Monday. The business has a fifty day simple moving average of $556.28 and a 200-day simple moving average of $532.97. The firm has a market cap of $175.18 billion, a price-to-earnings ratio of 76.73, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Insider Activity

In related news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. The trade was a 3.45 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, VP Fredrik Widman sold 810 shares of the company’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the sale, the vice president now directly owns 473 shares of the company’s stock, valued at approximately $271,397.94. This represents a 63.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 33,754 shares of company stock worth $17,691,621. Corporate insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have commented on ISRG shares. Erste Group Bank downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 17th. Evercore ISI lifted their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Leerink Partners increased their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. JPMorgan Chase & Co. lifted their target price on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, Royal Bank of Canada increased their price target on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.